Streetbeat News

Analyst Ratings

AMZN

WMT

The Federal Trade Commission (FTC) is reportedly preparing to file an antitrust lawsuit against Amazon (AMZN), which could suggest structural changes that may result in a company breakup. However, Wedbush analyst Michael Pachter believes that an outcome that materially alters Amazon's structure is unlikely, given the historical application of antitrust legislation and the evidence of a highly competitive U.S. retail market. Pachter reiterated Amazon with an Outperform and a $180 price target, suggesting buying Amazon shares on any weakness related to the FTC case headlines.

Portfolio Pulse from Anusuya Lahiri

September 15, 2023 | 5:14 pm

AAPL

Credit Suisse analyst Shannon Cross has reiterated an 'Outperform' rating on Apple (NASDAQ:AAPL) and maintained a price target of $220.

Portfolio Pulse from Benzinga Newsdesk

September 15, 2023 | 5:10 pm

NEM

A significant bullish stance has been taken on Newmont (NYSE:NEM) as evidenced by unusual options activity. The sentiment among these big-money traders is 80% bullish and 20% bearish. The price of NEM is up 2.14% at $40.37. RBC Capital downgraded its action to Sector Perform with a price target of $52, UBS maintained their Neutral rating with a price target of $42, and Raymond James maintained their Outperform rating with a price target of $61.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 5:04 pm

TLT

Financial experts Jim Bianco and Mohamed El-Erian have warned of a potential inflationary storm due to the surge in oil prices and the economy's resilience. They predict further interest rate hikes and a multi-year bear market for bonds. The iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT) has fallen 47% since its July 2020 highs. Bianco forecasts a rate hike in November and another at the start of 2024.

Portfolio Pulse from Piero Cingari

September 15, 2023 | 5:02 pm

SG

Analysts have provided various ratings for Sweetgreen (NYSE:SG) within the last quarter, with 1 bullish, 2 somewhat bullish, and 3 indifferent ratings. The average 12-month price target for Sweetgreen is $16.0, which has increased by 29.03% over the past month.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 5:01 pm

CMPR

Over the last quarter, Cimpress (NASDAQ:CMPR) has received 3 bullish and 1 somewhat bullish ratings from analysts. The average 12-month price target for the company has increased by 20.47% from the previous average, now standing at $88.75, with a high of $91.00 and a low of $87.00.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 5:00 pm

XPOF

Guggenheim has maintained its Buy rating for Xponential Fitness (NYSE:XPOF) but lowered its price target from $32.00 to $30.00. XPOF shares are currently trading down 3.41% at $18.11 per share. A move to $30.00 would represent a 65.65% increase from the current share price.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 5:00 pm

TRIP

In the last quarter, TripAdvisor (NASDAQ:TRIP) received 1 bullish, 6 indifferent, and 2 somewhat bearish ratings from analysts. The average 12-month price target for the company is $18.0, representing a 1.59% decrease from the previous average price target of $18.29.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 5:00 pm

BK

Bank of New York Mellon (NYSE:BK) has received 1 bullish and 3 somewhat bearish ratings from analysts in the last quarter. The average 12-month price target for the company is $50.25, representing a 1.95% decrease from the previous average price target of $51.25.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 5:00 pm

SLNO

Oppenheimer has maintained its Outperform rating for Soleno Therapeutics (NASDAQ:SLNO) and increased its price target from $8.00 to $14.00. Soleno Therapeutics' shares are currently trading up 8.37% over the last 24 hours, at $4.59 per share. A move to $14.00 would account for a 204.68% increase from the current share price.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 5:00 pm